Identification of gene products suppressed by human immunodeficiency virus type 1 infection or gp120 exposure of primary human astrocytes by rapid subtraction hybridization

被引:36
|
作者
Su, ZZ
Kang, DC
Chen, YM
Pekarskaya, O
Chao, W
Volsky, DJ
Fisher, PB
机构
[1] Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Dept Urol, New York, NY 10032 USA
[3] Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA
[4] Columbia Univ Coll Phys & Surg, Dept Neurosurg, New York, NY 10032 USA
[5] Columbia Univ, St Lukes Roosevelt Hosp Ctr, Div Mol Virol, New York, NY USA
关键词
AIDS; gp120; neuropathogenesis; Northern hybridization; reverse;
D O I
10.1080/13550280390201263
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurodegeneration and human immunodeficiency virus type 1 (HIV-1)-associated dementia ( HAD) are the major disease manifestations of HIV-1 colonization of the central nervous system (CNS). In the brain, HIV-1 replicates in microglial cells and infiltrating macrophages and it persists in a low-productive, noncytolytic state in astrocytes. Astrocytes play critical roles in the maintenance of the brain microenvironment, responses to injury, and in neuronal signal transmission, and disruption of these functions by HIV-1 could contribute to HAD. To better understand the potential effects of HIV-1 on astrocyte biology, the authors investigated changes in gene expression using an efficient and sensitive rapid subtraction hybridization approach, RaSH. Primary human astrocytes were isolated from abortus brain tissue, low-passage cells were infected with HIV-1 or mock infected, and total cellular RNAs were isolated at multiple time points over a period of 1 week. This approach is designed to identify gene products modulated early and late after HIV-1 infection and limits the cloning of genes displaying normal cell-cycle fluctuations in astrocytes. By subtracting temporal cDNAs derived from HIV-1-infected astrocytes from temporal cDNAs made from uninfected cells, 10 genes displaying reduced expression in infected cells, termed astrocyte suppressed genes (ASGs), were identified and their suppression was confirmed by Northern blot hybridization. Both known and novel ASGs, not reported in current DNA databases, that are down-regulated by HIV-1 infection are described. Northern blotting confirms suppression of the same panel of ASGs by treatment of astrocytes with recombinant HIV-1 envelope glycoprotein, gp120. These results extend our previous analysis of astrocyte genes induced or enhanced by HIV-1 infection and together they suggest that HIV-1 and viral proteins have profound effects on astrocyte physiology, which may influence their function in the CNS.
引用
收藏
页码:372 / 389
页数:18
相关论文
共 50 条
  • [1] Identification of gene products suppressed by human immunodeficiency virus type 1 infection or gp120 exposure of primary human astrocytes by rapid subtraction hybridization
    Zao-Zhong Su
    Dong-Chul Kang
    Yinming Chen
    Olga Pekarskaya
    Wei Chao
    David J. Volsky
    Paul B. Fisher
    Journal of NeuroVirology, 2003, 9 : 372 - 389
  • [2] Differential transcriptional regulation by human immunodeficiency virus type 1 and gp120 in human astrocytes
    D. Galey
    K. Becker
    N. Haughey
    A. Kalehua
    D. Taub
    J. Woodward
    M. P. Mattson
    A. Nath
    Journal of NeuroVirology, 2003, 9 : 358 - 371
  • [3] Differential transcriptional regulation by human immunodeficiency virus type 1 and gp120 in human astrocytes
    Galey, D
    Becker, K
    Haughey, N
    Kalehua, A
    Taub, D
    Woodward, J
    Mattson, MP
    Nath, A
    JOURNAL OF NEUROVIROLOGY, 2003, 9 (03) : 358 - 371
  • [4] Human herpesvirus 8 reactivation and human immunodeficiency virus type 1 gp120
    Lu, C
    Gordon, GM
    Chandran, B
    Nickoloff, BJ
    Foreman, KE
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2002, 126 (08) : 941 - 946
  • [5] Hidden dUTPase sequence in human immunodeficiency virus type 1 gp120
    Abergel, C
    Robertson, DL
    Claverie, JM
    JOURNAL OF VIROLOGY, 1999, 73 (01) : 751 - 753
  • [6] Identification of complement activation sites in human immunodeficiency virus type-1 glycoprotein gp120
    Susal, C
    Kirschfink, M
    Kropelin, M
    Daniel, V
    Opelz, G
    BLOOD, 1996, 87 (06) : 2329 - 2336
  • [7] Immunologic mechanism for human immunodeficiency virus type 1 gp120 vaccine failure
    OToole, C
    Muller, S
    Nara, P
    Kohler, H
    JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (02): : 512 - 513
  • [8] Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus
    Nagashunmugam, T
    Malamud, D
    Davis, C
    Abrams, WR
    Friedman, HM
    JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06): : 1635 - 1641
  • [9] MODEL FOR INTRACELLULAR FOLDING OF THE HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 GP120
    FENNIE, C
    LASKY, LA
    JOURNAL OF VIROLOGY, 1989, 63 (02) : 639 - 646
  • [10] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZATION IS DETERMINED BY EPITOPE EXPOSURE ON THE GP120 OLIGOMER
    SATTENTAU, QJ
    MOORE, JP
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01): : 185 - 196